Triple
T19923067
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Yoshihiro Kawaoka |
E478848
|
entity |
| Predicate | hasWorkedOn |
P922
|
FINISHED |
| Object | H5N1 influenza virus |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: H5N1 influenza virus | Statement: [Yoshihiro Kawaoka, hasWorkedOn, H5N1 influenza virus]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: H5N1 influenza virus Context triple: [Yoshihiro Kawaoka, hasWorkedOn, H5N1 influenza virus]
-
A.
Japanese encephalitis virus
Japanese encephalitis virus is a mosquito-borne flavivirus that causes severe inflammation of the brain in humans and is a leading cause of viral encephalitis in Asia.
-
B.
Nipah virus
Nipah virus is a highly lethal zoonotic paramyxovirus that causes severe respiratory illness and encephalitis in humans, with fruit bats as its natural reservoir.
-
C.
influenza B virus
Influenza B virus is a human-infecting respiratory virus that causes seasonal flu outbreaks and is one of the main types of influenza included in annual vaccines.
-
D.
influenza virus neuraminidase
Influenza virus neuraminidase is a surface enzyme on influenza viruses that enables the release and spread of new viral particles from infected cells and is a key target of antiviral drugs.
-
E.
influenza C virus
Influenza C virus is a type of influenza virus that primarily infects humans (and some animals), typically causing mild respiratory illness and lacking the neuraminidase protein found in other influenza types.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: H5N1 influenza virus Target entity description: The H5N1 influenza virus is a highly pathogenic avian flu strain that can cause severe respiratory illness and has raised global concern due to its potential to spark a deadly human pandemic.
-
A.
Japanese encephalitis virus
Japanese encephalitis virus is a mosquito-borne flavivirus that causes severe inflammation of the brain in humans and is a leading cause of viral encephalitis in Asia.
-
B.
Nipah virus
Nipah virus is a highly lethal zoonotic paramyxovirus that causes severe respiratory illness and encephalitis in humans, with fruit bats as its natural reservoir.
-
C.
influenza B virus
Influenza B virus is a human-infecting respiratory virus that causes seasonal flu outbreaks and is one of the main types of influenza included in annual vaccines.
-
D.
influenza virus neuraminidase
Influenza virus neuraminidase is a surface enzyme on influenza viruses that enables the release and spread of new viral particles from infected cells and is a key target of antiviral drugs.
-
E.
influenza C virus
Influenza C virus is a type of influenza virus that primarily infects humans (and some animals), typically causing mild respiratory illness and lacking the neuraminidase protein found in other influenza types.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e521855c8190b41871700afc8d6a |
completed | April 10, 2026, 11:55 a.m. |
| NER | Named-entity recognition | batch_69e659c7be948190a65a1c78ba68dff3 |
completed | April 20, 2026, 4:52 p.m. |
Created at: April 10, 2026, 1:53 p.m.